These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18098211)

  • 1. Infrapopliteal drug-eluting stents for chronic limb ischemia.
    Grant AG; White CJ; Collins TJ; Jenkins JS; Reilly JP; Ramee SR
    Catheter Cardiovasc Interv; 2008 Jan; 71(1):108-11. PubMed ID: 18098211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug eluting stents for below the knee lesions in patients with critical limb ischemia : long-term follow-up.
    Rosales OR; Mathewkutty S; Gnaim C
    Catheter Cardiovasc Interv; 2008 Jul; 72(1):112-5. PubMed ID: 18412272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial.
    Rastan A; Tepe G; Krankenberg H; Zahorsky R; Beschorner U; Noory E; Sixt S; Schwarz T; Brechtel K; Böhme C; Neumann FJ; Zeller T
    Eur Heart J; 2011 Sep; 32(18):2274-81. PubMed ID: 21622669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus for below the knee lesions: mid-term results of SiroBTK study.
    Commeau P; Barragan P; Roquebert PO
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):793-8. PubMed ID: 17039538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial.
    Rastan A; Brechtel K; Krankenberg H; Zahorsky R; Tepe G; Noory E; Schwarzwälder U; Macharzina R; Schwarz T; Bürgelin K; Sixt S; Tübler T; Neumann FJ; Zeller T
    J Am Coll Cardiol; 2012 Aug; 60(7):587-91. PubMed ID: 22878166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation.
    Zellweger MJ; Kaiser C; Brunner-La Rocca HP; Buser PT; Osswald S; Weiss P; Mueller-Brand J; Pfisterer ME;
    J Nucl Med; 2008 Apr; 49(4):550-6. PubMed ID: 18344439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia.
    Liistro F; Porto I; Angioli P; Grotti S; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    Circulation; 2013 Aug; 128(6):615-21. PubMed ID: 23797811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on PADI trial: percutaneous transluminal angioplasty and drug-eluting stents for infrapopliteal lesions in critical limb ischemia.
    Martens JM; Knippenberg B; Vos JA; de Vries JP; Hansen BE; van Overhagen H;
    J Vasc Surg; 2009 Sep; 50(3):687-9. PubMed ID: 19700099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit.
    Siablis D; Karnabatidis D; Katsanos K; Kagadis GC; Kraniotis P; Diamantopoulos A; Tsolakis J
    J Endovasc Ther; 2007 Apr; 14(2):241-50. PubMed ID: 17484536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infrapopliteal stents: overview and unresolved issues.
    Karnabatidis D; Katsanos K; Siablis D
    J Endovasc Ther; 2009 Feb; 16 Suppl 1():I153-62. PubMed ID: 19317574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.
    Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Slottow TL; Xue Z; Torguson R; Kaneshige K; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):496-500. PubMed ID: 19195509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
    Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
    Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
    Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus-eluting cobalt-chromium stents: two-year clinical results from first-in-man study on the Firebird 2 stent.
    Xu B; Zhang Q; Yang YJ; Qiao SB; Zhang RY; Zhang JS; Hu J; Qin XW; Hong T; Li JP; Chen JL; Huo Y; Gao RL; Shen WF
    Chin Med J (Engl); 2008 Mar; 121(6):492-7. PubMed ID: 18364131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting stents in the elderly: long-term (> one year) clinical outcomes of octogenarians in the DESIRE (Drug-Eluting Stents In the REal world) registry.
    Costa JR; Sousa A; Moreira AC; Costa RA; Maldonado G; Cano MN; Egito ET; Romano ER; Barbosa M; Pavanello R; Jardim C; Cury A; Berwanger O; Sousa JE
    J Invasive Cardiol; 2008 Aug; 20(8):404-10. PubMed ID: 18688065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-eluting stents for treatment of focal infrapopliteal lesions.
    Rastan A; Noory E; Zeller T
    Vasa; 2012 Mar; 41(2):90-5. PubMed ID: 22403126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
    Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.